tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

CSLLY Stock Latest News

Arcturus Therapeutics and CSL’s Kostaive COVID-19 vaccine approved in Europe
The FlyArcturus Therapeutics and CSL’s Kostaive COVID-19 vaccine approved in Europe
7d ago
ARCT
CSL, Arcturus Therapeutics announce European Commission approval for Kostaive
PremiumThe Fly
CSL, Arcturus Therapeutics announce European Commission approval for Kostaive
7d ago
ARCT
CSL Limited Earnings Call Highlights Growth and Challenges
PremiumCompany Announcements
CSL Limited Earnings Call Highlights Growth and Challenges
8d ago
CSL Limited Reports Strong Half-Year Financial Performance
PremiumCompany Announcements
CSL Limited Reports Strong Half-Year Financial Performance
10d ago
CSL initiated with a Buy at Goldman Sachs
PremiumThe Fly
CSL initiated with a Buy at Goldman Sachs
1M ago
CSL receives positive CHMP opinion for garadacimab in HAE
PremiumThe FlyCSL receives positive CHMP opinion for garadacimab in HAE
2M ago
Travere Therapeutics, CSL Vifor announce Swissmedic approval of FILSPARI
Premium
The Fly
Travere Therapeutics, CSL Vifor announce Swissmedic approval of FILSPARI
4M ago
TVTX
CSL joins Accumulus Synergy organization
Premium
The Fly
CSL joins Accumulus Synergy organization
5M ago
CSL, Arcturus Therapeutics announce Japan MHLW approval for Kostaive
PremiumThe Fly
CSL, Arcturus Therapeutics announce Japan MHLW approval for Kostaive
5M ago
ARCT
ARS Pharmaceuticals submits response for neffy MA, partners with CSL Seqirus
PremiumThe Fly
ARS Pharmaceuticals submits response for neffy MA, partners with CSL Seqirus
10M ago
SPRY
Arcturus Therapeutics’ and CSL’s COVID-19 vaccine shows longer immune response
PremiumThe Fly
Arcturus Therapeutics’ and CSL’s COVID-19 vaccine shows longer immune response
1y ago
ARCT
Arcturus Therapeutics and CSL’ ARCT-154 shows superior immunogenicity
PremiumThe Fly
Arcturus Therapeutics and CSL’ ARCT-154 shows superior immunogenicity
1y ago
ARCT
Arcturus Therapeutics, CSL publish data on booster dose of ARCT-154
PremiumThe FlyArcturus Therapeutics, CSL publish data on booster dose of ARCT-154
1y ago
ARCT
CSL upgraded to Conviction Buy from Buy at Goldman Sachs
Premium
The Fly
CSL upgraded to Conviction Buy from Buy at Goldman Sachs
1y ago
CSL’s and Arcturus Therapeutics’ mRNA vaccine for COVID approved in Japan
Premium
The Fly
CSL’s and Arcturus Therapeutics’ mRNA vaccine for COVID approved in Japan
1y ago
ARCT
CSL upgraded to Buy from Neutral at Goldman Sachs
PremiumThe Fly
CSL upgraded to Buy from Neutral at Goldman Sachs
1y ago
Jefferies healthcare analyst holds an analyst/industry conference call
PremiumThe Fly
Jefferies healthcare analyst holds an analyst/industry conference call
2y ago
Jefferies healthcare analyst holds an analyst/industry conference call
PremiumThe Fly
Jefferies healthcare analyst holds an analyst/industry conference call
2y ago
Jefferies healthcare analyst holds an analyst/industry conference call
PremiumThe Fly
Jefferies healthcare analyst holds an analyst/industry conference call
2y ago
CSL Seqirus begins shipping portfolio of flu vaccines for 2023/24 U.S. season
PremiumThe FlyCSL Seqirus begins shipping portfolio of flu vaccines for 2023/24 U.S. season
2y ago
CSL says first patient receives FDA-approved HEMGENIX in U.S.
Premium
The Fly
CSL says first patient receives FDA-approved HEMGENIX in U.S.
2y ago
CSL’s sparsentan did not achieve primary endpoint in glomerulosclerosis
Premium
The Fly
CSL’s sparsentan did not achieve primary endpoint in glomerulosclerosis
2y ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >